Inventiva (IVA) Non Operating Investment Income (2023 - 2024)

Inventiva (IVA) recorded quarterly Non Operating Investment Income of $109.7 million in Q4 2024, up 1297.39% quarter-over-quarter from -$9.2 million in Q2 2024, and up 26105.49% on a YoY basis from N/an in Q1 2024.

Inventiva (IVA) Non Operating Investment Income (2023 - 2024) Analysis & Trends

Inventiva's Non Operating Investment Income history runs 2 years deep, the most recent figure standing at $109.7 million for Q4 2024.

  • In Q4 2024, Non Operating Investment Income rose 26105.49% year-over-year to $109.7 million; the TTM figure through Dec 2024 stood at $109.7 million (up 26105.49% YoY), while the FY2024 annual figure was $109.7 million, up 26105.49% from the prior year.
  • Non Operating Investment Income was $109.7 million for Q4 2024 at Inventiva, up from -$9.2 million in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $109.7 million in Q4 2024 to a low of -$9.2 million in Q2 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 235,807.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 230,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Inventiva 8.52 Mn -260.21 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 109.68 Mn
Dec 31, 2024 109.68 Mn
Jun 30, 2024 -9.16 Mn
Jun 30, 2024 -9.16 Mn
Dec 31, 2023 418,540.62
Dec 31, 2023 418,540.62
Jun 30, 2023 -1.77 Mn
Jun 30, 2023 -1.77 Mn